345 related articles for article (PubMed ID: 29409348)
1. Better living through chemistry: Addressing emerging antibiotic resistance.
Coussens NP; Molinaro AL; Culbertson KJ; Peryea T; Zahoránszky-Köhalmi G; Hall MD; Daines DA
Exp Biol Med (Maywood); 2018 Mar; 243(6):538-553. PubMed ID: 29409348
[TBL] [Abstract][Full Text] [Related]
2. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
Medina E; Pieper DH
Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
[TBL] [Abstract][Full Text] [Related]
3. New antibiotic agents in the pipeline and how they can help overcome microbial resistance.
Gould IM; Bal AM
Virulence; 2013 Feb; 4(2):185-91. PubMed ID: 23302792
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics: past, present and future.
Hutchings MI; Truman AW; Wilkinson B
Curr Opin Microbiol; 2019 Oct; 51():72-80. PubMed ID: 31733401
[TBL] [Abstract][Full Text] [Related]
5. Addressing the frustrations of finding new effective antibacterials to combat drug resistant bacteria.
Fernandes P; Pizza M
Curr Opin Microbiol; 2008 Oct; 11(5):385-6. PubMed ID: 18804177
[No Abstract] [Full Text] [Related]
6. Progress in the Fight Against Multidrug-Resistant Bacteria 2005-2016: Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial Resistance.
Rex JH; Talbot GH; Goldberger MJ; Eisenstein BI; Echols RM; Tomayko JF; Dudley MN; Dane A
Clin Infect Dis; 2017 Jul; 65(1):141-146. PubMed ID: 29017263
[TBL] [Abstract][Full Text] [Related]
7. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.
Boucher HW; Talbot GH; Bradley JS; Edwards JE; Gilbert D; Rice LB; Scheld M; Spellberg B; Bartlett J
Clin Infect Dis; 2009 Jan; 48(1):1-12. PubMed ID: 19035777
[TBL] [Abstract][Full Text] [Related]
8. The antibiotic resistance crisis, with a focus on the United States.
Martens E; Demain AL
J Antibiot (Tokyo); 2017 May; 70(5):520-526. PubMed ID: 28246379
[TBL] [Abstract][Full Text] [Related]
9. The Potential of Antibiotics and Nanomaterial Combinations as Therapeutic Strategies in the Management of Multidrug-Resistant Infections: A Review.
Adeniji OO; Nontongana N; Okoh JC; Okoh AI
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499363
[TBL] [Abstract][Full Text] [Related]
10. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
Konreddy AK; Rani GU; Lee K; Choi Y
Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
[TBL] [Abstract][Full Text] [Related]
11. 2012 and beyond: potential for the start of a second pre-antibiotic era?
Appelbaum PC
J Antimicrob Chemother; 2012 Sep; 67(9):2062-8. PubMed ID: 22687888
[TBL] [Abstract][Full Text] [Related]
12. Overview: Global and Local Impact of Antibiotic Resistance.
Watkins RR; Bonomo RA
Infect Dis Clin North Am; 2016 Jun; 30(2):313-322. PubMed ID: 27208761
[TBL] [Abstract][Full Text] [Related]
13. Computational approaches in efflux pump inhibitors: current status and prospects.
Rathi E; Kumar A; Kini SG
Drug Discov Today; 2020 Oct; 25(10):1883-1890. PubMed ID: 32712312
[TBL] [Abstract][Full Text] [Related]
14. A call for antibiotic alternatives research.
Stanton TB
Trends Microbiol; 2013 Mar; 21(3):111-3. PubMed ID: 23473628
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005.
Finch R; Hunter PA
J Antimicrob Chemother; 2006 Sep; 58 Suppl 1():i3-i22. PubMed ID: 17003063
[TBL] [Abstract][Full Text] [Related]
16. Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.
O'Connell KM; Hodgkinson JT; Sore HF; Welch M; Salmond GP; Spring DR
Angew Chem Int Ed Engl; 2013 Oct; 52(41):10706-33. PubMed ID: 24038605
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities.
Penesyan A; Gillings M; Paulsen IT
Molecules; 2015 Mar; 20(4):5286-98. PubMed ID: 25812150
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Antibiotic Resistance.
Munita JM; Arias CA
Microbiol Spectr; 2016 Apr; 4(2):. PubMed ID: 27227291
[TBL] [Abstract][Full Text] [Related]
19. Selection of antibiotic-resistant pathogens in the community.
Yagupsky P
Pediatr Infect Dis J; 2006 Oct; 25(10):974-6. PubMed ID: 17006309
[TBL] [Abstract][Full Text] [Related]
20. Targeting bacterial topoisomerases: how to counter mechanisms of resistance.
Tse-Dinh YC
Future Med Chem; 2016 Jun; 8(10):1085-100. PubMed ID: 27285067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
